About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

U.S. Non-Invasive Prenatal Testing (NIPT) Market

U.S. Non-Invasive Prenatal Testing (NIPT) Market Is Set To Reach USD Billion By 2033, Growing At A CAGR Of 17.6

U.S. Non-Invasive Prenatal Testing (NIPT) Market by Product (Consumables & Reagents, Instruments), by Technology (Next Generation Sequencing (NGS), by End-User (Hospitals, Clinical Laboratories), by Forecast 2026-2034

Aug 10 2025

Base Year: 2025

100 Pages

U.S. Non-Invasive Prenatal Testing (NIPT) Market Is Set To Reach USD Billion By 2033, Growing At A CAGR Of 17.6

Key Insights

The U.S. Non-Invasive Prenatal Testing (NIPT) Market size was valued at USD 2.52 USD Billion in 2023 and is projected to reach USD 7.84 USD Billion by 2032, exhibiting a CAGR of 17.6 % during the forecast period. A screening test of the non-invasive prenatal test (NIPT) is devised which can detect the chromosomal aberration of a fetus with respect to the use of invasive procedures such as amniocentesis. It is right intended to diagnose Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 18). NIFP scans the DNA of the fetus which is taken to the mother's blood. Its types involve conventional DNA analysis as well as proteomic marker-based tests. Fingerprint patterns of the retina, like the fingerprint of one’s own, are unique. Also, features include higher precision and a lower false-positive rate than traditional screening techniques. The range of applications spans from delivering vital care for high-risk pregnancies to giving peace of mind to all expecting parents. The current market trend in the US suggests a rising number of women going for NIPT because it is a non-invasive mode of screening affording detection of more fatal abnormalities than its predecessor, thus is becoming increasingly popular.

U.S. Non-Invasive Prenatal Testing (NIPT) Trends

Growing adoption of NIPT to screen for Down syndrome, trisomy 18, and trisomy 13.
Increasing use of NIPT for sex determination and microdeletion syndromes testing.
Technological advancements and the development of novel NIPT techniques such as cfDNA sequencing and single-nucleotide polymorphism (SNP) genotyping.

U.S. Non-Invasive Prenatal Testing (NIPT) Market Market Size and Forecast (2024-2030) — U.S. Non-Invasive Prenatal Testing (NIPT) Market Company Market Share

Driving Forces: What's Propelling the U.S. Non-Invasive Prenatal Testing (NIPT) Market

The Aging Maternal Population: A significant rise in the average age of first-time mothers in the U.S. directly correlates with a heightened risk of chromosomal abnormalities like Down syndrome, Trisomy 18, and Trisomy 13, fueling demand for NIPT.
Enhanced Prenatal Care Initiatives: The increasing emphasis on preventative healthcare and minimizing adverse birth outcomes is driving wider adoption of NIPT as a crucial component of comprehensive prenatal screening.
Expanding Insurance Coverage and Reimbursement: Broader insurance coverage and favorable reimbursement policies for NIPT are significantly reducing out-of-pocket costs for expectant parents, making the test more accessible and driving market growth.
Heightened Awareness and Increased Physician Recommendation: A growing understanding among both healthcare professionals and expectant parents regarding the benefits of early and accurate detection of fetal anomalies through NIPT is leading to increased testing rates.
Technological Innovation and Improved Test Accuracy: Continuous advancements in NIPT technology, leading to improved accuracy, sensitivity, and reduced turnaround times, are enhancing the appeal and efficacy of the test.
The Rise of Personalized Medicine: The burgeoning field of personalized medicine and the increasing demand for proactive genetic testing are further contributing to the expanding market for NIPT, empowering expectant parents with crucial genetic information.
Competitive Pricing and Market Consolidation: The presence of multiple players offering competitive pricing and the ongoing market consolidation among NIPT providers are driving further accessibility and affordability.

Challenges and Restraints in the U.S. Non-Invasive Prenatal Testing (NIPT) Market

Lack of awareness about NIPT among certain population groups.
Potential for false-positive and false-negative results.
Ethical concerns associated with the use of NIPT.
High costs associated with NIPT testing.

Emerging Trends in U.S. Non-Invasive Prenatal Testing (NIPT)

Development of non-invasive prenatal screening tests for a wider range of genetic conditions.
Integration of NIPT with artificial intelligence and machine learning for improved accuracy.
Adoption of NIPT in low-resource settings.
Personalized NIPT based on maternal and fetal characteristics.

Growth Catalysts in the U.S. Non-Invasive Prenatal Testing (NIPT) Industry

Increasing research and development in the field of NIPT.
Strategic partnerships and collaborations between key players.
Government initiatives to promote NIPT awareness and adoption.
Technological advancements and the development of more sensitive and accurate NIPT methods.

Market Segmentation: U.S. Non-Invasive Prenatal Testing (NIPT) Analysis

Product:

Instruments and Consumables
Reagents

Technology:

Next Generation Sequencing (NGS)
Microarray
Polymerase Chain Reaction (PCR)
Rolling Circular Amplification (RCA)

End-User:

Hospitals
Clinical Laboratories

Leading Players in the U.S. Non-Invasive Prenatal Testing (NIPT) Market

Significant Developments in U.S. Non-Invasive Prenatal Testing (NIPT) Sector

Recent Developments:

**June 2023:** PerkinElmer launched the Vanadis NIPT Advance, a highly sensitive and comprehensive NIPT test.
**April 2023:** Natera announced the acquisition of InVitae, a leader in genetic information services.
**February 2023:** Illumina unveiled the Verifi InVitae NIPT, which incorporates carrier screening and expanded genetic analysis.

Previously Mentioned Developments:**September 2022:** YOURGENE HEALTH received Health Sciences Authority (HSA) approval for its IONA Nx NIPT Workflow in Singapore for use in clinical laboratories.**September 2022:** Eurofins Genoma launched a non-invasive preimplantation genetic aneuploidy screening test (niPGT-A).**May 2021:** YOURGENE HEALTH announced the launch of the Accelerator Phase for its Microdeletions Plugin, which expanded the clinical menu and capabilities of the class-leading IONA Nx NIPT Workflow offering.Additional Recent Developments:**January 2023:** Roche Diagnostics acquired Genpatac, a molecular diagnostics company specializing in non-invasive prenatal testing.**October 2022:** Illumina introduced the Verifi Panorama NIPT Plus test, offering expanded genetic information for expectant mothers.**July 2022:** Natera launched the Prospera NIPT test, which screens for over 100 genetic conditions, including aneuploidies and microdeletions.

Comprehensive Coverage U.S. Non-Invasive Prenatal Testing (NIPT) Market Report

Market Overview
Market Size and Forecast
Drivers, Challenges, and Trends
Segment Analysis
Competitive Landscape
Company Profiles
SWOT Analysis
Key Developments
Regional Insight
DROCT (Demographics, Regulatory, Occupational, Competitive, and Technological)
Pricing Analysis
Import and Export Analysis
Patent/Trademark Analysis

U.S. Non-Invasive Prenatal Testing (NIPT) Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 17.6% from 2020-2034
Segmentation	By Product Consumables & Reagents Instruments By Technology Next Generation Sequencing (NGS By End-User Hospitals Clinical Laboratories By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Rising Technological Developments in Products to Propel Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Rising Consequences of False Results to Restrict the Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product
  - 5.1.1. Consumables & Reagents
  - 5.1.2. Instruments
- 5.2. Market Analysis, Insights and Forecast - by Technology
  - 5.2.1. Next Generation Sequencing (NGS
- 5.3. Market Analysis, Insights and Forecast - by End-User
  - 5.3.1. Hospitals
  - 5.3.2. Clinical Laboratories
- 5.4. Market Analysis, Insights and Forecast - by Region
  - 5.4.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Illumina Inc. (U.S.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 YOURGENE HEALTH (U.K.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Natera (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 F. Hoffmann-La Roche Ltd (Switzerland)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 PerkinElmer Inc. (U.S.)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Laboratory Corporation of America Holdings (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Eurofins LifeCodexx GmbH (Germany)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Agilent Technologies Inc (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue Breakdown (USD Billion, %) by Product 2025 & 2033
Figure 2: U.S. Non-Invasive Prenatal Testing (NIPT) Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by Product 2020 & 2033
Table 2: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by Technology 2020 & 2033
Table 3: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by End-User 2020 & 2033
Table 4: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by Region 2020 & 2033
Table 5: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by Product 2020 & 2033
Table 6: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by Technology 2020 & 2033
Table 7: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by End-User 2020 & 2033
Table 8: U.S. Non-Invasive Prenatal Testing (NIPT) Market Revenue USD Billion Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Non-Invasive Prenatal Testing (NIPT) Market?

The projected CAGR is approximately 17.6%.

2. Which companies are prominent players in the U.S. Non-Invasive Prenatal Testing (NIPT) Market?

Key companies in the market include Illumina, Inc. (U.S.), YOURGENE HEALTH (U.K.), Natera (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Eurofins LifeCodexx GmbH (Germany), Agilent Technologies, Inc (U.S.).

3. What are the main segments of the U.S. Non-Invasive Prenatal Testing (NIPT) Market?

The market segments include Product, Technology, End-User.

4. Can you provide details about the market size?

The market size is estimated to be USD 2.52 USD Billion as of 2022.

5. What are some drivers contributing to market growth?

Rising Technological Developments in Products to Propel Market Growth.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Rising Consequences of False Results to Restrict the Market Growth.

8. Can you provide examples of recent developments in the market?

September 2022 - YOURGENE HEALTH received Health Sciences Authority (HSA) approval for its IONA Nx NIPT Workflow in Singapore for use in clinical laboratories.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD Billion.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Non-Invasive Prenatal Testing (NIPT) Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Non-Invasive Prenatal Testing (NIPT) Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Non-Invasive Prenatal Testing (NIPT) Market?

To stay informed about further developments, trends, and reports in the U.S. Non-Invasive Prenatal Testing (NIPT) Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Non-Invasive Prenatal Testing Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

Non-Invasive Prenatal Testing XX CAGR Growth Outlook 2025-2033

Non-invasive Prenatal Genetic Testing Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Non-invasive Prenatal Paternity Testing(NIPPT) 2025 to Grow at XX CAGR with XXX million Market Size: Analysis and Forecasts 2033

Non-Invasive Prenatal Paternity Test (NIPP) Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report